Items where Author is "Dodi, IA"

Up a level
Export as [feed] RSS
Group by: Item Type | No Grouping
Number of items: 42.

Journal article

DE, L., MADRIGAL, J.A., RUSAKIEWICZ, S., BENCSIK, M., CAVE, G.W.V., SELMAN, A., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2009. Artificial exosomes as tools for basic and clinical immunology. Journal of Immunological Methods, 344 (2), pp. 121-132. ISSN 0022-1759

KAPOOR, K.N., BARRY, D.T., REES, R.C., DODI, I.A., MCARDLE, S.E.B., CREASER, C.S. and BONNER, P.L.R., 2009. Estimation of peptide concentration by a modified bicinchoninic acid assay. Analytical Biochemistry, 393 (1), pp. 138-140.

MONTGOMERY, H.V., DODI, I.A. and TANAKA, K., 2006. Applications of nitrocellulose film coated MALDI targets in proteomics. Molecular & Cellular Proteomics, 5 (10). ISSN 1535-9476

DE, L., MADRIGAL, J.A., BENESIK, M., CAVE, G.W.V., SELMAN, A., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2006. Artificial super para magnetic nano APC for active and adoptive immunotherapy. Blood, 108 (11). ISSN 0006-4971

SZMANIA, S., GALLOWAY, A., BRUORTON, M., MUSK, P., AUBERT, G., ARTHUR, A., PYLE, H., HENSEL, N., TA, N., LAMB, J., DODI, I.A., MADRIGAL, A., BARRETT, J., HENSLEE-DOWNEY, J. and VAN, R., 2006. Isolation and expansion of cytomegalovirus-specific cytotoxic T lymphocytes to clinical scale from a single blood draw using dendritic cells and HLA-tetramers. Blood, 98 (3), pp. 505-512. ISSN 1528-0020

KAPOOR, K., MATHIEU, M., REES, R.C., CREASER, C.S., DODI, I.A. and BONNER, P.L.R., 2006. Isolation and identification of phosphopeptides from K562 cells. Journal of Peptide Science, 12, p. 85. ISSN 1075-2617

STANLEY, S.M., DODI, I.A., EVANS, C.R., PASTON, S.J., REES, R.C., PERCIVAL, C.J., MCHALE, G. and NEWTON, M.I., 2006. Layer-guided acoustic plate mode biosensors for monitoring MHC-peptide interactions. Analyst, 131 (8), pp. 892-894. ISSN 0003-2654

DE, L., MADRIGAL, J.A., BENCSIK, M., CAVE, G.W.V., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. Blood, 106 (11), p. 3907.

DE, L., MADRIGAL, J.A., BENCSIK, M., CAVE, G.W.V., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. Blood, 106 (11), p. 3907. ISSN 0006-4971

RODRIGUEZ, T., MENDEZ, R., ROBERTS, C.H., RUIZ-CABELLO, F., DODI, I.A., NEVOT, M.A.L., PACO, L., MALENO, I., MARSH, S.G.E., PAWELEC, G. and GARRIDO, F., 2005. High frequency of homozygosity of the HLA region in melanoma cell lines reveals a pattern compatible with extensive loss of heterozygosity. Cancer Immunology Immunotherapy, 54 (2), pp. 141-148. ISSN 0340-7004

MADRIGAL, J.A., TRAVERS, P.J. and DODI, I.A., 2005. Immunotherapeutic aspects of stem cell transplantation. Hematology, 10, pp. 289-292. ISSN 1024-5332

RUSAKIEWICZ, S., DODI, I.A., LOCONTO, J., TRAVERS, P.J. and MADRIGAL, J.A., 2004. Can BCR/ABL breakpoint fusion peptides be used as a target for GVL immunotherapy by expanding peptide specific T cells in patients in vivo? Blood Cells Molecules and Diseases, 33 (3), p. 191. ISSN 1079-9796

ROBERTS, C.H., ROBINSON, J., DODI, I.A., MADRIGAL, J.A. and MARSH, S.G.E., 2004. The European searchable tumour cell line database (ESTDAB). Genes and Immunity, 5. ISSN 1466-4879

ZAL, B., KASKI, J.C., ARNO, G., AKIYU, J.P., XU, Q.B., COLE, D., WHELAN, M., RUSSELL, N., MADRIGAL, J.A., DODI, I.A. and BABOONIAN, C., 2004. Heat-shock protein 60-reactive CD4(+)CD28(null) T cells in patients with acute coronary syndromes. Circulation, 109 (10), pp. 1230-1235. ISSN 0009-7322

CHEN, F.E., WEN, W.S., HUANG, G.W., TRAVERS, P., DODI, I.A. and MADRIGAL, J.A., 2004. High frequency CD4+CD25+ Treg cells in nasopharyngeal carcinoma is associated with suppression of CD8 T cell mediated response to latency II EBV antigens. Blood, 104 (11). ISSN 0006-4971

MADRIGAL, A.J., RUSAKIEWIEZ, S., DODI, I.A. and REES, R., 2004. Immunotherapy with alloreactive T-cells? Hematology Journal, 5 (3). ISSN 1466-4860

CHEN, F.E., DUARTE, R., BARBER, L., DODI, I.A., TRAVERS, P. and MADRIGAL, A., 2002. Antigen-specific CTL expanded with dendritic cells are skewed towards effector phenotype. Tissue Antigens, 59, p. 43. ISSN 0001-2815

DODI, I.A., VAN, R., FORDE, H.C., ROURA-MIR, C., JARAQUEMADA, D., GOLDMAN, J.M. and MADRIGAL, J.A., 2002. CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy, 4 (4), pp. 353-363. ISSN 1465-3249

DODI, I.A., RUSAKIEWICZ, S., AUBERT, G., CLARKE, R., CHRISTMAS, S., CREASER, C., BONNER, P., REES, R., TRAVERS, P.J. and MADRIGAL, J.A., 2002. Definition of the breakpoint fusion peptides for HLA-A3 and HLA-B8 in CML cells. Tissue Antigens, 59, p. 45. ISSN 0001-2815

CHEN, F.E., AUBERT, G., TRAVERS, P., DODI, I.A. and MADRIGAL, J.A., 2002. HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy, 4 (1), pp. 41-48. ISSN 1465-3249

AUBERT, G., HASSAN-WALKER, A.F., MADRIGAL, J.A., EMERY, V.C., MORTE, C., GRACE, S., KOH, M.B.C., POTTER, M., PRENTICE, H.G., DODI, I.A. and TRAVERS, P.J., 2001. Cytomegalovirus-specific cellular immune responses and viremia in recipients of allogeneic stem cell transplants. Journal of Infectious Diseases, 184 (8), pp. 955-963. ISSN 0022-1899

CLARK, R.E., DODI, I.A., HILL, S.C., LILL, J.R., AUBERT, G., MACINTYRE, A.R., ROJAS, J., BOURDON, A., BONNER, P.L.R., WANG, L.H., CHRISTMAS, S.E., TRAVERS, P.J., CREASER, C.S., REES, R.C. and MADRIGAL, J.A., 2001. Direct evidence that leukemic cells present HLA-associated immunogenic peptides derived from the BCR-ABL b3a2 fusion protein. Blood, 98 (10), pp. 2887-2893. ISSN 0006-4971

PAWELEC, G., REES, R.C., KIESSLING, R., MADRIGAL, A., DODI, I.A., BAXEVANIS, C., GAMBACORTI-PASSERINI, C., MASUCCI, G. and ZEUTHEN, J., 1999. Cells and cytokines in immunotherapy and gene therapy of cancer. Critical Reviews in Oncogenesis, 10, pp. 83-127. ISSN 0893-9675

MORTE, C., DODI, I.A., MORGAN, C.L., PAY, A.L., TRAVERS, P.J. and MADRIGAL, J.A., 1999. Release of IFN gamma by NK and T-cells as a measure of the immune response to CMV infection in CMV-positive and CMV-negative individuals. Blood, 94 (10). ISSN 0006-4971

DODI, I.A., VAN, R., ROURA-MIR, C., FORDE, H., FISCHER, G., JARAQUEMADA, D., GOLDMAN, J.M. and MADRIGAL, J.A., 1998. Analysis of TCR V(beta) usage in T cell lines showing specificity for autologous leukaemic cells generated from a patient receiving DLT for relapse following BMT IA. Bone Marrow Transplantation, 21. ISSN 0268-3369

ARGUELLO, J.R., LITTLE, A.M., BOHAN, E., GALLARDO, D., O'SHEA, J., DODI, I.A., GOLDMAN, J.M. and MADRIGAL, J.A., 1998. A high resolution HLA class I and class II matching method for bone marrow donor selection. Bone Marrow Transplantation, 22 (6), pp. 527-534. ISSN 0268-3369

VANRHEE, F., DODI, I.A., FORDE, H., PEREZ, I., FISHER, G., GOLDMAN, J.M. and MADRIGAL, J.A., 1996. CD4 positive leukemia specific T cell clones are present during the graft-versus-leukemia response after allogeneic bone marrow transplantation for chronic myeloid leukemia. Human Immunology, 49, p. 38. ISSN 0198-8859

DODI, I.A., VANRHEE, F., FORDE, H., CRUZ, I.P., FISCHER, G., GOLDMAN, J.M. and MADRIGAL, J.A., 1996. Graft-versus-leukaemia (GVL) effect post allogeneic BMT is mediated by CML specific T cell clones. Human Immunology, 47, p. 463. ISSN 0198-8859

VANRHEE, F., DODI, I.A., FORDE, H., CRUZ, I.P., FISCHER, G., GOLDMAN, J.M. and MADRIGAL, J.A., 1996. Graft-versus-leukaemia effect (GVL) post allogeneic BMT is mediated by CML specific T cell clones. British Journal of Haematology, 93, p. 297. ISSN 0007-1048

KHAKOO, S.I., LING, R., HORTEGA, E., SCOTT, I., DODI, I.A., COHEN, S.B.A., LITTLE, A.M., HARRISON, T.J., MADRIGAL, J.A. and DUSHEIKO, G.M., 1996. The cytotoxic T lymphocyte (CTL) response in chronic hepatitis B infection. Use of an HLA class I matched dual transfectant model. Hepatology, 24 (4), p. 391. ISSN 0270-9139

DODI, I.A., VANRHEE, F., FORDE, H., GOLDMAN, J.M. and MADRIGAL, J.A., 1995. Examination of T cell clones derived from patients receiving DLT relapse following bone marrow transplantation. Blood, 86 (10), p. 2843. ISSN 0006-4971

BATCHELOR, J.R., FIELDER, A.H.L., WALPORT, M.J., DAVID, J., LORD, D.K., DAVEY, N., DODI, I.A., MALASIT, P., WANACHIWANAWIN, W., BERNSTEIN, R., MACKWORTHYOUNG, C. and ISENBERG, D., 1987. Family Study of the Major Histocompatibility Complex in Hla Dr3 Negative Patients with Systemic Lupus-Erythematosus. Clinical and Experimental Immunology, 70 (2), pp. 364-371. ISSN 0009-9104

FRANCIS, D.A., BATCHELOR, J.R., MCDONALD, W.I., DODI, I.A., HING, S.N., HERN, J.E.C. and DOWNIE, A.W., 1987. Hla Genetic-Determinants in Familial Ms - A Study from the Grampian Region of Scotland. Tissue Antigens, 29 (1), pp. 7-12. ISSN 0001-2815

FRANCIS, D.A., BATCHELOR, J.R., MCDONALD, W.I., HING, S.N., DODI, I.A., FIELDER, A.H.L., HERN, J.E.C. and DOWNIE, A.W., 1987. Multiple-Sclerosis in Northeast Scotland - An Association with Hla-Dqw1. Brain, 110, pp. 181-196. ISSN 0006-8950

CANNIFF, J.P., BATCHELOR, J.R., DODI, I.A. and HARVEY, W., 1985. Hla-Typing in Oral Submucous Fibrosis. Tissue Antigens, 26 (2), pp. 138-142. ISSN 0001-2815

GILES, C.M., BATCHELOR, J.R., DODI, I.A., FIELDER, A.H.L., RITTNER, C., MAUFF, G., BENDER, K., LEVENE, C., SCHREUDER, G.M.T. and WELLS, L.J., 1984. C-4 and Hla Haplotypes Associated with Partial Inhibition of Anti-Rg and Anti-Ch. Journal of Immunogenetics, 11, pp. 305-317. ISSN 0305-1811

BATCHELOR, J.R., FIELDER, A.H.L., WALPORT, M.J., RYNES, R.I., BLACK, C.M., DODI, I.A. and HUGHES, G.R.V., 1984. Genetic Susceptibility to Systemic Lupus-Erythematosus. European Surgical Research, 16 (1), p. 66. ISSN 0014-312X

FIELDER, A.H.L., WALPORT, M.J., BATCHELOR, J.R., RYNES, R.I., BLACK, C.M., DODI, I.A. and HUGHES, G.R.V., 1983. Family Study of the Major Histocompatibility Complex in Patients with Systemic Lupus-Erythematosus - Importance of Null Alleles of C4A and C4B in Determining Disease Susceptibility. British Medical Journal, 286 (6363), pp. 425-428. ISSN 0959-8138

SOUTAR, C.A., COUTTS, I., PARKES, W.R., DODI, I.A., GAULD, S., CASTRO, J.E. and TURNERWARWICK, M., 1983. Histocompatibility Antigens in Coal-Miners with Pneumoconiosis. British Journal of Industrial Medicine, 40 (1), pp. 34-38. ISSN 0007-1072

Chapter in book

CREASER, C.S., LILL, J.R., BONNER, P.L.R., HILL, S.C., REES, R.C., CHRISTMAS, S.C., CLARK, R., NORBURY, L., DODI, I.A. and MADRIGAL, A.J., 2001. Characterisation of HLA-A3 restricted peptide from the BCR-ABL fusion protein of the Philadelphia chromosome using nano-electrospray ion trap mass spectrometry. In: E. GELPI, ed., Advances in mass spectrometry. John Wiley & Sons, pp. 637-638.

Conference contribution

DE, L., MADRIGAL, J.A., BENCSIK, M., CAVE, G.W.V., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2005. Hemato nanotechnology: artificial APC system for T cell adoptive and active immunotherapy. In: 47th Annual Meeting of the American Society of Hematology, Atlanta, GA, USA, 10-13 December 2005, Atlanta, GA, USA.

DE, L., MADRIGAL, J.A., BENESIK, M., CAVE, G.W.V., SELMAN, A., REES, R.C., TRAVERS, P.J. and DODI, I.A., 2001. Artificial super para magnetic nano APC for active and adoptive immunotherapy. In: Symposium of the International Society of Molecular Evolution, Guananacaste, Costa Rica, 8-12 January 2001, Guananacaste, Costa Rica.

This list was generated on Mon Nov 20 12:25:28 2017 UTC.